Lawyer Urges China To Launch Own Probe Of Pfizer Bribery Allegations
This article was originally published in PharmAsia News
Executive Summary
A Beijing lawyer has urged Chinese authorities to conduct their own investigation of Pfizer's alleged bribes of regulators and medical workers in China.
A Beijing lawyer has urged Chinese authorities to conduct their own investigation of Pfizer's alleged bribes of regulators and medical workers in China. The lawyer asked the Supreme People's Procuratorate to look into the matter in the wake of the U.S. company's $15 million settlement with its government covering allegations it and its subsidiaries made improper payments in eight countries, including China. The settlement was based on a U.S. Securities and Exchange Commission complaint of such payments as far back as 2001, which Pfizer neither denied nor admitted. Payments in question also were said to have been made in Indonesia and Pakistan. (Click here for more)
"Pfizer Facing Possible Fines Over Bribery Claim" - China Daily (8/16/2012)